Ekaterina Poguzhelskaya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ekaterina Poguzhelskaya has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Ahmed Gaballa
Department of Epileptology, Krankenhaus Mara, Bethel Epilepsy Center Bielefeld University Bielefeld Germany
2 shared publications - Angelika Mühlebner
Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands
2 shared publications - Antonio Gil-Nagel
Hospital Ruber Internacional Madrid Spain
2 shared publications - Daniel Delev
Department of Neurosurgery Friedrich Alexander University Erlangen‐Nürnberg, partner of European Reference Network EpiCARE Erlangen Germany
2 shared publications - Florian Mayer
Department of Pediatrics and Adolescent Medicine Medical University Vienna, partner of European Reference Network EpiCARE Vienna Austria
2 shared publications - Friedrich Gerrit Woermann
Department of Epileptology, Krankenhaus Mara, Bethel Epilepsy Center, Medical School OWL, Bielefeld University, Bielefeld, Germany
2 shared publications
Latest Publications
- Open Access
Repetitive clustered low‐voltage fast activity on intracranial electroencephalogram in mild malformation of cortical development with oligodendroglial hyperplasia and epilepsy: A candidate electroencephalographic biomarker study
Objective: Mild malformation of cortical development with oligodendroglial hyperplasia and epilepsy (MOGHE) is a recently recognized cause of drug‐resistant focal epilepsy. It is often magnetic resonance imaging‐negative or radiologically resembles focal cortical dysplasias, which makes recognition difficult and limits presurgical counseling. We aimed to identify an intracranial electroencephalographic (iEEG) biomarker that distinguishes MOGHE from other developmental brain lesions encountered in epilepsy surgery. Methods: We analyzed long‐term stereo‐EEG and subdural recordings in a retrospective multicenter test cohort (18 MOGHE, 20 non‐MOGHE) to identify an iEEG pattern distinguishing MOGHE from other developmental brain lesions. We then evaluated its diagnostic performance by blinded visual assessment in an independent single‐center validation cohort (11 MOGHE, 11 non‐MOGHE). Firth‐penalized multivariable logistic regression tested whether MOGHE histology independently predicted the presence of this pattern after adjustment for spasms, frontal localization, age at seizure onset, and age at implantation. Finally, within MOGHE, we assessed whether resection of the territory exhibiting this pattern was associated with postsurgical seizure freedom. Results: We identified highly stereotyped clusters of very brief low‐voltage fast activity (LVFA), recurring in statuslike episodes lasting several minutes and sometimes lacking clear clinical symptoms. LVFA clusters occurred in 16 of 18 MOGHE and in no non‐MOGHE patients in the test cohort. In the validation cohort, visual identification of LVFA clusters correctly classified 10 of 11 MOGHE and 10 of 11 non‐MOGHE cases (overall agreement = 90.9%, 95% Wilson confidence interval = 72.2%–97.5%). MOGHE histology was the dominant independent predictor of LVFA clusters. Within MOGHE, resection of LVFA cluster territory was associated with postsurgical seizure freedom (Mann–Whitney U ‐test, p = .0021). Significance: Because LVFA clusters can be recognized visually on routine iEEG without specialized software, they may provide a clinically applicable candidate biomarker for presurgical identification of MOGHE and support surgical planning and outcome prediction. Prospective studies should validate their diagnostic and prognostic utility.
Open AccessRepetitive clustered low‐voltage fast activity on intracranial electroencephalogram in mild malformation of cortical development with oligodendroglial hyperplasia and epilepsy: A candidate electroencephalographic biomarker study
Objective: Mild malformation of cortical development with oligodendroglial hyperplasia and epilepsy (MOGHE) is a recently recognized cause of drug‐resistant focal epilepsy. It is often magnetic resonance imaging‐negative or radiologically resembles focal cortical dysplasias, which makes recognition difficult and limits presurgical counseling. We aimed to identify an intracranial electroencephalographic (iEEG) biomarker that distinguishes MOGHE from other developmental brain lesions encountered in epilepsy surgery. Methods: We analyzed long‐term stereo‐EEG and subdural recordings in a retrospective multicenter test cohort (18 MOGHE, 20 non‐MOGHE) to identify an iEEG pattern distinguishing MOGHE from other developmental brain lesions. We then evaluated its diagnostic performance by blinded visual assessment in an independent single‐center validation cohort (11 MOGHE, 11 non‐MOGHE). Firth‐penalized multivariable logistic regression tested whether MOGHE histology independently predicted the presence of this pattern after adjustment for spasms, frontal localization, age at seizure onset, and age at implantation. Finally, within MOGHE, we assessed whether resection of the territory exhibiting this pattern was associated with postsurgical seizure freedom. Results: We identified highly stereotyped clusters of very brief low‐voltage fast activity (LVFA), recurring in statuslike episodes lasting several minutes and sometimes lacking clear clinical symptoms. LVFA clusters occurred in 16 of 18 MOGHE and in no non‐MOGHE patients in the test cohort. In the validation cohort, visual identification of LVFA clusters correctly classified 10 of 11 MOGHE and 10 of 11 non‐MOGHE cases (overall agreement = 90.9%, 95% Wilson confidence interval = 72.2%–97.5%). MOGHE histology was the dominant independent predictor of LVFA clusters. Within MOGHE, resection of LVFA cluster territory was associated with postsurgical seizure freedom (Mann–Whitney U ‐test, p = .0021). Significance: Because LVFA clusters can be recognized visually on routine iEEG without specialized software, they may provide a clinically applicable candidate biomarker for presurgical identification of MOGHE and support surgical planning and outcome prediction. Prospective studies should validate their diagnostic and prognostic utility.
- Open Access
A novel diagnostic intracranial EEG biomarker in MOGHE
Mild malformation of cortical development with oligodendroglial hyperplasia and epilepsy (MOGHE) is a recently recognized cause of drug-resistant focal epilepsy. It is often MRI-negative or shows imaging features mimicking focal cortical dysplasias, which makes recognition difficult and limits presurgical counseling. We aimed to identify an intracranial EEG (iEEG) biomarker that distinguishes MOGHE from other developmental brain lesions encountered in epilepsy surgery. In a retrospective multicenter test cohort of 38 patients (18 MOGHE, 20 non-MOGHE), we analyzed long-term stereo-EEG and subdural recordings. Only MOGHE patients showed highly stereotyped clusters of very brief low-voltage fast activity (LVFA) events, organized into status-like 3 to 12-minute episodes that often lacked clear clinical symptoms. LVFA clusters were present in 16/18 MOGHE and 0/22 non-MOGHE patients. We then tested diagnostic performance in an independent, blinded single-center validation cohort of 22 patients (11 MOGHE, 11 non-MOGHE), in which visual identification of LVFA clusters correctly classified 10/11 MOGHE and 10/11 non-MOGHE cases (Cohen’s κ=0.82). Penalized logistic regression further confirmed MOGHE histology as the strongest predictor of LVFA clusters, independent of age and lobe localization. Because LVFA clusters can be recognized visually on routine intracranial EEG recordings without specialized software, this biomarker is readily applicable in clinical practice and may improve presurgical identification of MOGHE. Future prospective studies should determine whether its recognition influences surgical planning, improves outcome prediction, or facilitates selection of patients for mechanism-based therapies. Highlights: Clusters of brief LVFA in intracranial EEG are a lesion-specific biomarker of MOGHE compared to mMCD and FCD2 LVFA clusters reliably distinguished MOGHE from non-MOGHE lesions (mMCD and FCD2) in both a multicenter test cohort and an independent blinded validation cohort. Younger age at seizure onset is a secondary independent modifier, while frontal localization and age at intracranial recording are not. Clinicians can detect LVFA clusters on continuous intracranial EEG using routine montages and ≥60-second review windows, without any specialized software. LVFA clusters show a characteristic temporal organization and burden in MOGHE, indicating a distinct pattern of pathological network activity in this lesion type.
Open AccessA novel diagnostic intracranial EEG biomarker in MOGHE
Mild malformation of cortical development with oligodendroglial hyperplasia and epilepsy (MOGHE) is a recently recognized cause of drug-resistant focal epilepsy. It is often MRI-negative or shows imaging features mimicking focal cortical dysplasias, which makes recognition difficult and limits presurgical counseling. We aimed to identify an intracranial EEG (iEEG) biomarker that distinguishes MOGHE from other developmental brain lesions encountered in epilepsy surgery. In a retrospective multicenter test cohort of 38 patients (18 MOGHE, 20 non-MOGHE), we analyzed long-term stereo-EEG and subdural recordings. Only MOGHE patients showed highly stereotyped clusters of very brief low-voltage fast activity (LVFA) events, organized into status-like 3 to 12-minute episodes that often lacked clear clinical symptoms. LVFA clusters were present in 16/18 MOGHE and 0/22 non-MOGHE patients. We then tested diagnostic performance in an independent, blinded single-center validation cohort of 22 patients (11 MOGHE, 11 non-MOGHE), in which visual identification of LVFA clusters correctly classified 10/11 MOGHE and 10/11 non-MOGHE cases (Cohen’s κ=0.82). Penalized logistic regression further confirmed MOGHE histology as the strongest predictor of LVFA clusters, independent of age and lobe localization. Because LVFA clusters can be recognized visually on routine intracranial EEG recordings without specialized software, this biomarker is readily applicable in clinical practice and may improve presurgical identification of MOGHE. Future prospective studies should determine whether its recognition influences surgical planning, improves outcome prediction, or facilitates selection of patients for mechanism-based therapies. Highlights: Clusters of brief LVFA in intracranial EEG are a lesion-specific biomarker of MOGHE compared to mMCD and FCD2 LVFA clusters reliably distinguished MOGHE from non-MOGHE lesions (mMCD and FCD2) in both a multicenter test cohort and an independent blinded validation cohort. Younger age at seizure onset is a secondary independent modifier, while frontal localization and age at intracranial recording are not. Clinicians can detect LVFA clusters on continuous intracranial EEG using routine montages and ≥60-second review windows, without any specialized software. LVFA clusters show a characteristic temporal organization and burden in MOGHE, indicating a distinct pattern of pathological network activity in this lesion type.